Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8

被引:1
|
作者
Rennen, HJJM
Boerman, OC
Oyen, WJG
van der Meer, JWM
Corstens, FHM
机构
[1] Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
interleukin-8; infection; scintigraphic imaging; biodistribution; Tc-99m;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Interleukin-8 (IL-8) is a chemotactic cytokine involved in activation and recruitment of neutrophils to areas of infection. In our previous studies in rabbits we tested I-123-labeled IL-8 for its potential to image infections and showed that IL-8 rapidly and efficiently accumulated in infectious foci. However, labeling of IL-8 with I-123 is costly and laborious and the specific activity of the preparation was low. In this study IL-8 was labeled with Tc-99m through the hydrazinonicotinamide (HYNIC) chelator. Methods: The leukocyte receptor-binding capacity of the preparation was determined in vitro. Rabbits with Escherichia coli abscesses were injected intravenously with 7 MBq Tc-99m-HYNIC-IL-8. Biodistribution of the radiolabel was determined by gamma camera imaging and tissue counting at 8 h after injection. Tc-99m-HYNIC-lysozyme was used as a size-matched control. Results: The leukocyte receptor-binding capacity of the Tc-99m-HYNIC-IL-8 preparation was preserved as determined in vitro, but labeling efficiency was modest with a specific activity of 3 MBq/mug. Tc-99m-HYNIC-IL-8 accumulated rapidly in the abscess up to 0.33 +/- 0.06 percentage injected dose per gram (%ID/g) at 8 h after injection (vs. 0.025 +/- 0.003 %ID/g for 99mTc-HYNIC-lysozyme). Total uptake in the abscess was 4.9 +/- 0.7 %ID (vs. 0.44 +/- 0.05 %ID for 99mTc-HYNIC-lysozyme). Abscess-to-contralateral muscle ratios increased up to 127 +/- 23 (compared with 6.7 +/- 1.1 for Tc-99m-HYNIC-lysozyme) and abscess-to-blood ratios increased to 11.9 +/- 2.2 (0.24 +/- 0.03 for 99mTc-HYNIC-lysozyme). The radiolabel was excreted renally, with a retention in the kidneys of 28 %ID. Gamma camera imaging rapidly visualized the abscess from 1 h after injection onward, with abscess-to-background ratios improving with time up to 22 at 8 h after injection (vs. 2.7 for Tc-99m-HYNIC-lysozyme), as determined by quantitative analysis of the images. Most important, only a transient (30 min) moderate drop of leukocyte counts and no leukocytosis were observed after injection of an imaging dose of 99mTc-HYNIC-IL-8. Conclusion: IL-8 can be labeled with (TC)-T-99m using HYNIC as a chelator. By this method the leukocyte receptor-binding capacity is preserved. The preparation allows rapid visualization of infection in a rabbit model with high target-to-background ratios. The mild transient drop of leukocyte counts and the absence of leukocytosis suggest that Tc-99m-HYNIC-IL-8 may be used as an imaging agent with only mild and transient side effects.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 50 条
  • [41] Detection of colon cancer with 99mTc-labeled bombesin derivative (99mTc-leu13-BN1)
    Scopinaro, F
    De Vincentis, G
    Corazziari, E
    Massa, R
    Osti, M
    Pallotta, N
    Covotta, A
    Remediani, S
    Di Paolo, M
    Monteleone, F
    Varvarigou, A
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (02) : 245 - 252
  • [42] 99mTc-labeled Nanocolloid scintigraphy in the assessment of splenosis
    Di Palo, A.
    Iuele, F.
    Altini, C.
    Asabella, A. Niccoli
    Nicoletti, A.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S215 - S215
  • [43] Synthesis and biological characterization of 99mTc-labeled ciprofloxacin
    V. S. Skuridin
    N. V. Varlamova
    M. L. Belyanin
    S. I. Sazonova
    Yu. N. Konkovskaya
    R. M. Takhauov
    Pharmaceutical Chemistry Journal, 2009, 43 : 516 - 520
  • [44] Imaging of atherosclerotic evolution with 99mTc-labeled duramycin
    Liu, Zhonglin
    Gray, Brian
    Barber, Christy
    Furenlid, Lars
    Pak, Koon
    Woolfenden, James
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [45] Pharmacokinetics and renal handling of 99mTc-labeled peptides
    Trejtnar, F
    Laznicek, M
    Laznickova, A
    Mather, SJ
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (01) : 177 - 182
  • [46] SYNTHESIS AND BIOLOGICAL CHARACTERIZATION OF 99mTC-LABELED CIPROFLOXACIN
    Skuridin, V. S.
    Varlamova, N. V.
    Belyanin, M. L.
    Sazonova, S. I.
    Konkovskaya, Yu. N.
    Takhauov, R. M.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2009, 43 (09) : 516 - 520
  • [47] Development methods for 99mTc-labeled nanocolloidal preparations
    Sadkin, V.
    Rov, E. Nest.
    Uridin, V. S.
    Stasyuk, E.
    Rogov, A.
    Varlamova, N.
    Zelchan, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S197 - S197
  • [48] 99mTc-labeled nanocolloid drugs: development methods
    Vladimir Sadkin
    Viktor Sкuridin
    Evgeny Nesterov
    Elena Stasyuk
    Alexander Rogov
    Natalya Varlamova
    Roman Zelchan
    Scientific Reports, 10
  • [49] Clinical Utility of 99mTc-Labeled Ubiquicidin 29-41 Antimicrobial Peptide for the Scintigraphic Detection of Mediastinitis after Cardiac Surgery
    Vallejo, Enrique
    Martinez, Irma
    Tejero, Alberto
    Hernandez, Salvador
    Jimenez, Luis
    Bialostozky, David
    Sanchez, Gustavo
    Ilarraza, Hermes
    Ferro-Flores, Guillermina
    ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (08) : 768 - 774
  • [50] Test of Radiochemical Purity in 99mTc-labeled Pharmaceuticals
    Mathiasen, S. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S453 - S453